Please login to the form below

Not currently logged in
Email:
Password:

Therapy Area

This page shows the latest Therapy Area news and features for those working in and with pharma, biotech and healthcare.

EU approval for Opdivo combo in renal cell cancer

EU approval for Opdivo combo in renal cell cancer

This follows US approval last year, and is the first Immuno-Oncology (IO) combination therapy for patients with this type of cancer in the European Union. ... These rival combinations have produced trial data suggesting they could also help a wider

Latest news

More from news
Approximately 0 fully matching, plus 205 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    The therapy area is dominated by Merck’s Keytruda, BMS’ Opdivo and Roche’s Tecentriq, but Pfizer is hoping that combinations such as its own Inlyta and Bavencio can help it ... It has gene therapy deals with Spark in haemophilia and with Sangamo in

  • Trust me, I’m from pharma Trust me, I’m from pharma

    The pioneering companies are those who are not focused simply on selling their drugs – they are committed to a therapy area, committed to the experts and, fundamentally, committed to the patients.

  • Developing advocacy in the pharmaceutical industry Developing advocacy in the pharmaceutical industry

    But if you or your company is new to a therapy area, you may wish to use KOL profiling or mapping to help identify the right candidates.

  • Patient outcomes in practice: delivering value that transforms lives Patient outcomes in practice: delivering value that transforms lives

    Our mindset needs to change. In our planning meetings we need to discuss how we can change patients’ lives in a therapy area, what outcomes matter to patients, and how we

  • A marathon and a sprint A marathon and a sprint

    He responded that he currently has reps from five large pharmaceutical companies offering him the exact same ‘added-value’ service within the same therapy area. ... Although the congress had over 1, 000 delegates, the experience we created targeted

More from intelligence
Approximately 0 fully matching, plus 46 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 70 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics